A group from IDIBELL and the Bellvitge University Hospital has shown that a genetic variant of the bacterium would be associated with higher production of biofilm, a self-protection system that allows it to persist in the environment.
So far, the collaboration between IDIBELL and the Institut Bellvitge has allowed six students to carry out their research work at the IDIBELL facilities and see first-hand the work carried out there.
Let’s Tandem: Research Works Read More »
Neurofibromas are tumors of the peripheral nervous system, which develop in people with a hereditary disease, and they are the main cause of death among those people.
A study just published in the journal Nature Medicine, led has discovered that two antibodies naturally present in humans are responsible for triggering the immune response that causes the deterioration of heart implants of animal origin
A study by IDIBELL and ICO in collaboration with Uppsala University analyzes antitumor immune activity in encapsulated metastases compared to unencapsulated ones.
The histology of liver metastases from colon cancer could influence immunotherapy Read More »
Using the earthworm C. elegans as a model, a group of researchers from IDIBELL and ICO has shown that a diet rich in glucose accentuates the effect of cisplatin and that dopamine protects against the neurotoxic effects of the drug.
The initiative wants to promote and consolidate this ecosystem located in the south of the Barcelona metropolitan area with the creation of new infrastructures and new services
Today, February 11th is the International Day of Women and Girls in Science, and we want to highlight the importance of having mentors.
The relevance of our female mentors Read More »
The study shows no differences in complications that require hospitalization between people with COVID-19 who received intravenous plasma infusion and those who did not.
Convalescent plasma treatment against COVID-19 is not effective Read More »
The study opens the way to the potential use of inhibitors of this miRNA as a therapeutic strategy to stop the progression of this vascular condition
